E
CTSO icon

Ergoteles’s Cytosorbents Corp CTSO Stock Holding History

Ergoteles’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,009
Closed -$68K – 1122
2023
Q1 		$68K Sell
1,009
-3,852
-79% -$231K ﹤0.01% 1119
2022
Q4 		$151K Sell
4,861
-4,014
-45% -$119K 0.01% 1148
2022
Q3 		$241K Sell
8,875
-1,260
-12% -$49.2K 0.01% 1088
2022
Q2 		$444K Buy
+10,135
New +$465K 0.01% 893

Other funds holding CTSO

Skylands Capital
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
Avenir Corporation
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Granahan Investment Management
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Sargent Investment Group
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jacob Asset Management of New York
Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return

Ergoteles's CTSO Position: Q2 2023 in Review

Ergoteles sold out of Cytosorbents Corp (CTSO) in Q2 2023, closing a stake of 1,009 shares — an estimated $68K sold.

Ergoteles first reported a position in CTSO in Q2 2022 and held it in 4 quarters. The position peaked at $444K in Q2 2022. 57 funds tracked by Wall St. Rank hold CTSO as of Q2 2023.

  • Ergoteles reported no remaining Cytosorbents Corp position as of Q2 2023 after selling out during the quarter.
  • Ergoteles sold 1,009 Cytosorbents Corp shares in Q2 2023, an estimated $68K.
  • Ergoteles first reported a position in Cytosorbents Corp in Q2 2022 and held it in 4 quarters.
  • Ergoteles's Cytosorbents Corp position peaked at $444K in Q2 2022.
  • 57 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2023.

Based on Ergoteles's 13F filing for Q2 2023, filed 14 Aug 2023.